2017

  1. Kristiansen A, Drevin L, Delahunt B, Samaratunga H, Robinson D, Franck Lissbrant I, Stattin P, Egevad L. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study, Pathology. 2017 Dec;49(7):715-720. Sammanfattning
  2. Thomsen FB, Sandin F, Garmo H, Lissbrant IF, Ahlgren G, Van Hemelrijck M, Adolfsson J, Robinson D, Stattin P. Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study, Eur Urol. 2017 Dec;72(6):920-928.  Sammanfattning
  3. Jonas Hugosson, Pär Stattin. Kvaliteten på radikal prostatektomi måste säkerställas- Fortlöpande förbättringsarbete behövs på varje klinik – med patientenkäter kan enskilda kirurgers resultat följas upp. Läkartidningen 2017: 114:EP36
  4. Rajan P, Sooriakumaran P, Nyberg T, Akre O, Carlsson S, Egevad L, Steineck G, Wiklund NP. Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study, J Clin Oncol. 2017 Nov 1;35(31):3566-3574. Sammanfattning
  5. Van Hemelrijck M, Garmo H, Lindhagen L, Bratt O, Stattin P, Adolfsson J. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer, Eur Urol. 2017 Oct;72(4):534-541. Sammanfattning
  6. Loeb S, Folkvaljon Y, Curnyn C, Robinson D, Bratt O, Stattin P. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden, JAMA Oncol. 2017 Oct 1;3(10):1393-1398. Sammanfattning
  7. Fridriksson JÖ, Folkvaljon Y, Lundström KJ, Robinson D, Carlsson S, Stattin P. Long-term adverse effects after retropubic and robot-assisted radical prostatectomy. Nationwide, population-based study, J Surg Oncol. 2017 Sep;116(4):500-506. Sammanfattning
  8. Sooriakumaran P, Nyberg T, Akre O, Widmark A, Hamdy F, Graefen M, Carlsson S, Steineck G, Wiklund NP. Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy, Eur Urol. 2017 Sep;72(3):345-351. Sammanfattning
  9. Stattin P, Sandin F, Thomsen FB, Garmo H, Robinson D, Lissbrant IF, Jonsson H, Bratt O. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study, Eur Urol. 2017 Jul;72(1):125-134. Sammanfattning
  10. Licciardello MP, Ringler A, Markt P, Klepsch F, Lardeau CH, Sdelci S, Schirghuber E, Müller AC, Caldera M, Wagner A, Herzog R, Penz T, Schuster M, Boidol B, Dürnberger G, Folkvaljon Y, Stattin P, Ivanov V, Colinge J, Bock C, Kratochwill K, Menche J, Bennett KL, Kubicek S. A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor, Nat Chem Biol. 2017 Jul;13(7):771-778. Sammanfattning
  11. Robertson S, Adolfsson J, Stattin P, Sjövall A, Winnersjö R, Hanning M, Sandelin K. Waiting times for cancer patients in Sweden: A nationwide population-based study, Scand J Public Health. 2017 May;45(3):230-237. Sammanfattning
  12. Loeb S, Folkvaljon Y, Damber JE, Alukal J, Lambe M, Stattin P. Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer, J Clin Oncol. 2017 May 1;35(13):1430-1436. Sammanfattning
  13. Bosco C, Garmo H, Adolfsson J, Stattin P, Holmberg L, Nilsson P, Gunnlaugsson A, Widmark A, Van Hemelrijck M. Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events, Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1026-1031. Sammanfattning
  14. Häggström C, Van Hemelrijck M, Zethelius B, Robinson D, Grundmark B, Holmberg L, Gudbjörnsdottir S, Garmo H, Stattin P. Prospective study of Type 2 Diabetes Mellitus, anti-diabetic drugs, and risk of prostate cancer, Int J Cancer. 2017 Feb 1;140(3):611-617. Sammanfattning
  15. Danneman D, Drevin L, Delahunt B, Samaratunga H, Robinson D, Bratt O, Loeb S, Stattin P, Egevad L. The Accuracy of Prostate Biopsies for Predicting Gleason Score in Radical Prostatectomy Specimens. Nationwide trends 2000-2012, BJU Int. 2017 Jan;119(1):50-56. Sammanfattning